GORMAN KEVIN CHARLES bought NBIX
May 21, 2025 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 6,610 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,610
Price
$0.00
Total value
N/A
InsiderGORMAN KEVIN CHARLES
Role—
SecurityNon-Qualified Stock Option
Transaction codeA: Grant or award
Transaction dateMay 21, 2025
Filing dateMay 22, 2025
Shares owned after6,610
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Option vests in 12 monthly installments beginning June 21, 2025.